Upon stimulation with the cytokine interferon-γ human monocytes/macrophages produce neopterin. Accordingly, measurement of neopterin concentrations in body fluids like blood, urine or cerebrospinal fluid provides information about activation of immune response involving type 1 Τ helper cells. Increased neopterin production is found in infections by viruses including human immunodeficiency virus (HIV), infections by intracellular living bacteria and parasites, autoimmune diseases, malignant tumor diseases and in allograft rejection episodes, but also in some neurodegenerative and in cardiovascular diseases. Major diagnostic applications of neopterin measurements are monitoring of the immune status of allograft recipients, detection of infectious diseases in blood donations and monitoring of therapy in HIV-infected individuals. Neopterin concentrations also provide prognostic information in HIV-infected individuals and in several malignant tumor diseases, high neopterin production at the moment of diagnosis is associated with poorer survival expectations. As high neopterin production is associated with increased production of reactive oxygen species and with low serum concentrations of antioxidants like α-tocopherol, neopterin can be regarded as a marker of oxidative stress caused by an activated immune system. Therefore, by neopterin measurements not only the extent of cellular immune activation, but also the extent of tissue damage caused by reactive oxygen specics may be estimated.
Introduction
Neopterin, 2-amino-4-hydroxy-6-(D-erythro-l 2', 3'-trihydroxypropyl)-pteridine ( Fig.l) , belongs to the hydroxylase is not affected, but the biosynthesis of the necessary cofactor 5. 6, 7, 8-tetrahydrobiopterin (H4-bip) is disturbed. In the same year, Helmut Wächter and coworkers described increased neopterin concentrations in patients suffering from malignant diseases but also in patients with virus infections (6) and thereby opened a much broader area for the application of neopterin measurements. While searching for a tumor marker, this first result appeared rather disappointing at the first glancc, however, at the end this finding was a basis for a remarkable variety of applications of neopterin determination (7) (8) (9) (10) (11) . which also contributed to a deeper understanding of the complex interrelationship between immune response and pathogenesis of diseases. 6-pyruvoyl tctrahydroptenn synthase to form dihydrobiopterin in the biosynthetic pathway of H4-bip. H4-Qip is an essential cofactor of several mono-oxygenases including phenylalanine-, tyrosine-and tryptophans-hydroxylase, and the nitric oxide synthases (12) . When GTP-cyclohydrolase I is activated, most cells like fibroblasts or endothelial cells of several species produce H4-bip and only scarce amounts of neopterin derivatives are formed. However, due to a relative deficiency of 6-pyruvoyl tetrahydropterin synthase in human and primate monocytes/macrophages, activation of GTP cyclohydrolase I leads to an accumulation of H2-nep-triphosphate at the expense of H4-bip. H2-Nep-triphosphate is then converted by phosphatases to neopterin and H2-nep ( Fig. 2 ) (13) . The latter products are detectable in cell culture supernatants of activated human monocytes/macrophages and in body fluids of humans and primates in a rather constant ratio of neopterin per H2-nep of about 1:3 (14) . From this background, human monocytes/macrophages appear to constitute the most relevant source of neopterin and H2-nep. Interferon-γ (IFN-γ) is the central stimulus for the activation of GTP cyclohydrolase I, and therefore in human monocytes/macrophages neopterin and H2-nep accumulate (15) . Besides, also lipopolysaccharide and tumor necrosis factor-α (TNF-α) superinduce IFN-y-mediated neopterin production (16) .
Immunological background of neopterin biosynthe-
Upon stimulation with interferons also monocytederived dendritic cells were found to produce neopterin in similar concentrations as macrophages (17) . Other cells like human umbilical vein endothelial cells (18) or cultured kidney epithelial cells (19) , may produce neopterin upon stimulation with IFN-γ, but to a smaller extent than macrophages (19) . In addition, neopterin production by epithelial cells is accompanied by production of H4-bip (20) . As in human diseases like, e.g., infections by human immunodeficiency virus (HIV), increased neopterin but no or only slight changes of bioplerin production can be found (21) , in case of immune stimulation by IFN-γ neopterin is mainly produced by human macrophages and not by epithelial cells (22) .
In patients several cytokines such as, e.g. interleukin-(IL)-2, which are able to induce IFN-γ -release from Τ cells, also provoke neopterin release (23) . Similarly, administration of granulocyte/monocyte stimulating factor (GM-CSF) enhances neopterin production in patients (24) probably by increasing the number of monocytes/macrophages.
As IL-2 and especially IFN-γ are cytokines typically produced by Τ helper (Th) cells subtype 1 (25) , which are promoting immune response mediated by cytotoxic Τ cells, increased production of neopterin in body fluids can be used to monitor activation of cellmediated immunity. Accordingly, diseases like, e.g., virus infections are accompanied by increased neopterin production, because cell mediated immune response dominates (6, 7) . On the other hand, in situations like, e.g., acute bacterial infections, only moderate neopterin production can be found. In this case. Th2 cell immune response dominates, characterized by Schroecksnadel Κ. et a!.: Neopterin to Monitor Clinical Pathologies Involving IFN-γ Production the formation of IL-4, -5. -6, -9, -10 and -13, which are supporting humoral immune response (26) . A crossregulatory influence exists between Thl-type and Th2-type immune responses, down-regulating each other when activated (Fig. 3) . This is evident from in vitro Th1-type cell G Th2-type cell Figure 3 : During activation of Thl-type immune response in humans and primates, cytokine interferon-γ (IFN-γ) stimulates macrophages to produce neopterin derivatives in parallel to reactive oxygen species such as H 2 0 2 . Thl-type cytokines down-regulate Th2-type cells, vice versa, Th2-type cytokines like inlerlekin-4 (IL-4) and -10 (IL-10) suppress Thl-type response and neopterin production. Cytokines and chemicals (e.g. antioxidants) suppressing Thl-type cells and the production of Thl-type cytokines also affect rate of neopterin formation. (27) and in vivo investigations. Neopterin concentrations in human serum, which reflect Thl cell activity, were compared to serum antibody concentrations, which are a product of Th2 cell activation. Inverse correlation between neopterin concentrations and antibody levels were found (28, 29) . However, sometimes an activation of both Τ helper cell-compartments alternatively or a shift to the ThO phenotype seems to exist (30) . E.g., in acute episodes of graft-versus-host disease after human allogeneic bone marrow transplantation, a significant positive correlation between plasma neopterin levels and the Th2-derived cytokine IL-10 was found (31) . The amount of neopterin secreted by human monocytes/macrophages upon stimulation with IFN-γ correlates with the capacity of the same cells to produce reactive oxygen species (ROS) (32, 33) , neopterin derivatives may be regarded as an indicator for oxidative stress due to immune activation as well (34. 35) .
The biological impact of neopterin derivatives
A biological function of increased neopterin production by the activated human macrophages has not been demonstrated by now, but recently neopterin derivatives were found to interfere with reactive oxygen species in vitro (36) (37) (38) (39) (40) (41) (42) . Therefore it seems possible that neopterin derivatives influence the effects and cytotoxicity of reactive oxygen species like hydrogen peroxide which are produced by activated macrophages within the oxidative burst reaction. Formation of nitric oxide by stimulated human macrophages seems to be of limited relevance (43) , although in in vitro investigations human macrophages could be stimulated to produce nitric oxide, but only after rather complex pretreatment with cytokines such as IL-4 (44). Rather it seems that production of neopterin derivatives may compensate for the relative deficiency to produce nitric oxide in human and primate macrophages (45) by modulating the toxicity ol other reactive oxygen species like hydrogen peroxide.
From in vitro investigations it may further be hypothesized that neopterin and H2-nep may act as endogenous agents influencing redox balances in biological systems (34) . Neopterin and H2-nep were also found to interfere with intracellular signaling pathways known to be influenced by oxidative stress (46. 47; see also Hoffmann G & Schobersberger W, this issue of Pteridines). Moreover, neopterin was found to induce additional production of reactive oxygen species by granulocytes recently (48) . In vivo observations are able to further substantiate the relationship between increase of neopterin concentrations and production of oxidizing compounds: In older-aged people (49) and in elderly demented patients with neurodegenerative diseases (50) an inverse correlation between increased neopterin levels and decreased levels of the antioxidant α-tocopherol was found. In patients with diabetic nephropathy a correlation was found between neopterin and advanced oxidation protein products (33) , the latter compounds represent a reliable indicator for the degree of oxidant-mediatcd protein damage. Therefore, the result suggests a relation between oxidative stress and monocyte activation as monitored by neopterin concentrations. The data agree well with the conclusion that neopterin is not only a indicator for oxidative stress resulting from immune activation, but neopterin itself contributes to oxidative stress by modulating the effects of ROS (34) .
Measurement of neopterin concentrations in biological fluids
Neopterin and H2-nep are small molecular mass molecules (253 and 255 D), which are produced and released in a remarkably constant proportion with a ratio of aromatic neopterin to total (aromatic plus acid-oxidizable H2-nep) neopterin of 1:3 for urine and arterial blood (14) and 1:2 for serum obtained from venous blood samples. Since dihydroforms of pteridines are labile, collection and storage of samples is critical and problematic for large scale clinical handling. In daily clinical routine, advantageously only the more stable neopterin is being quantified. Serum neopterin may be determined by immunoassays in an easy way, neopterin concentrations averaging 5.3 ± 2.7 nM in healthy adults, 95"' percentile being 8.7 nM for adults aged between 19 and 75 years (8, 9, 51) . Cerebrospinal fluid concentrations of neopterin were found to be lower than serum (4.2 ± 1.0; upper limit of normal 5.5 nM) (51; for more details of the application of neopterin determinations in cerebrospinal fluid see also Hagberg L, et al., this issue of Pteridines). Since neopterin is constantly distributed in body fluids, alternative or additional measurement of neopterin concentrations in urine specimens as compared with serum or plasma can be performed. To take variations of urine densities into account, urinary neopterin concentrations are expressed in μηιοΐ/mol creatinine which can advantageously be done by examining samples by high-pressure liquid chromatography (52) . Reference values of urinary neopterin per creatinine concentrations are slightly influenced by gender and age (8, 9, 11) : as compared with males (average neopterin concentrations ranging between 101 -133 pmol/mol creatinine; 97.5th percentiles ranging for 176 -229 μιτιοΐ/mol creatinine), females present with higher levels (average neopterin concentrations ranging between 124 -156 pmol/mol creatinine; 97.5" 1 percentiles ranging for 208 -251 μηιοΐ/mol creatinine) mostly because of lower creatinine excretion, in both groups of individuals older age is associated with increasing neopterin concentrations (8, 9, 11) .
Neopterin determination in clinical laboratory immunology
In diseases like infections, autoimmune and malignant tumor diseases or in cases of allograft rejection ccllular immune activation is clearly involved in the pathogenesis or affected by the underlying disease process, but also in neurological and cardiovascular diseases immunological processes are discussed. To clarify pathogenesis and finding appropriate therapy, early and sensitive monitoring of immunological changes in patients but also in vitro experiments with cells involved in immune reactions could be important. By measurements of neopterin in human body fluids or cell culture supernatants monitoring of cellular immune activation can by easily done.
Neopterin in infectious diseases
Upon recognition of foreign or non-self cell structures T-lymphocytes may produce different mediators, so-called lymphokines, such as interferon-γ. which stimulates human monocytes/macrophages to the production and release of neopterin (15) . During acute viral infections strongly increased neopterin production can be observed, which correlates with the activity of the disease. This was shown in, e.g., acute viral hepatitis, Epstein-Barr-virus and cytomegalovirus infections, measles, mumps, chickenbox, rubella and influenza (7, 9, 53 -57) . Elevated neopterin levels in body fluids may already be found at the end of the incubation period just before onset of clinical symptoms. The highest neopterin levels occur just before specific antibodies against the virus become detectable, which occurs up to about two to four weeks after onset of increased neopterin production. On seroconversion, neopterin concentrations decline and normalize, if the immune system successfully competes the infecting agent (Fig. 4) . This sequence of events appears to be true for every acute virus infection (58) , and it was also observed in, e.g., Ebola virus infections when high concentrations of neopterin in plasma were observed as soon as a few days after the disease onset and were indicative of a fatal outcome (59) . By contrast, in HIV infection, neopterin concentrations increase during acute infection and decline after sero-conversion, but do not normalize (60) . Thus, more than three quarters of the HIV-infected still show elevated neopterin production although being without symptoms (7, 61) . From these neopterin data the crucial role of immune activation in the pathogenesis of the acquired immunodeficiency syndrome (AIDS) has been deduced very early (62): Activated T-cells are more susceptible to HIV infection and activation of infected T-cells induces virus replication (Fig. 5) .
tion (70, 71) .
In acute bacterial infections neopterin production is usually low, as humoral immune response dominates. Therefore neopterin measurements could be an additional tool to support differential diagnosis between viral and bacterial infection in special clinical situations. This was reported in patients with pneumonia, where neopterin discriminated better than blood sedimentation rate or leukocyte counts between viral and HIV binds to T-cell via CD4 receptor 2 nd step:
Activation of T-helper cells as pre-requisite for progressive HIV infection e.g. co-infections Already in the early phase of HIV infection, neopterin concentrations have prognostic impact: The higher the neopterin concentration in serum or urine, the higher will be the risk to develop (AIDS). With disease progression neopterin production increases again with the highest values when full-blown AIDS develops, paralleled by decreasing CD4+ T-lymphocyte counts (62) (63) (64) (65) (66) (67) . In general, neopterin concentrations provide similar prognostic values for disease progression as other predictive markers like CD4 T-cell counts or quantitative PCR for HIV RNA. Neopterin values also correlate with viral load (68, 69) . Antiretroviral therapy is reflected in a decrease of neopterin producbacterial infection (26, 72) . In protracted bacterial infection neopterin production increases. Highest neopterin concentrations in body fluids are found in case of septic complications (73) due to lipopolysaccharides of Gram-negative bacteria like, e.g., Pseudomonas pseudomallei (74) or Brucella melitensis (75) . On the other hand, bacteria like Streptococcus pyogenes produce exotoxins with superantigen character (76) , which are supposed to play a key role in the so called "streptococcal toxic shock like syndrome" which is associated with high neopterin production as well (77) .
In infections by Mycobacterium tuberculosis, a fac- In infections with parasites, like acute malaria, high neopterin formation was found (82, 83) . After effective chemotherapy elevated concentrations in serum or urine rapidly decrease to normal values within several days (84) . An inverse association between the duration of parasitic load and neopterin production was found, indicating that with duration of the disease humoral immunity develops while severity of the disease and cellular immune activation decline (85) .
In infections with Borrelia burgdorferi, a tick-born spirochete, which may cause so called Lyme neuroborreliosis, high neopterin concentrations are found in cerebrospinal fluid of patients, whereas serum neopterin levels are only slightly increased indicating intrathecal neopterin production in Lyme neuroborreliosis (86. 87).
Neopterin in malignant tumor diseases
As malignant tumor cells exhibit an altered cell-surface compared to non-malignant cells, they may provoke reactions of the specific cellular immune system and thereby also neopterin production. The frequency of elevated neopterin concentrations in serum or urine of patients with malignant diseases at the moment of diagnosis depends on the tumor type and varies from about 90% in hematological neoplasias like chronic myelogenous leukemia, non-Hodgkin's disease or Hodgkin's disease, to about 20% in tumors like breast cancer or malignant melanoma (88) . Intermediate frequencies of elevated neopterin concentrations are found in ovarian cancer and uterine sarcoma (about 80%), pancreatic carcinoma and multiple myeloma (about 70%), lung cancer (about 58%), cervix carcinoma (about 55%) and colon and stomach carcinoma (40%). Therefore neopterin measurements are certainly insufficient for screening or diagnostic purposes, however neoptenn determination was proposed as a diagnostic aid to identify individuals with increased risk for breast cancer in menopausal women with genetic predisposition (89) .
Not only tumor type, but also tumor stage influence the extent of neopterin elevation. In general, advanced stages show higher neopterin values than earlier ones. On the other hand, successful treatment, indicated by remission in hematological neoplasias, is associated with decline or even normalization of neopterin values in most cases (88) . Also a correlation between urinary neopterin levels and the estimated total mass of tumor cells was shown (90) . The most striking observation from several studies on malignant tumor diseases is that neopterin concentrations proved to be a significant and independent predictor of patients' survival. Higher urinary or serum neopterin concentrations were associated with a worse outcome. This was shown, e.g., in hematological neoplasias (91) (92) , in carcinoma of the uterine cervix (93) or of the ovaries (94), in colon carcinoma (95) , lung cancer (96, 97) , prostate cancer (98), hepatocellular cancer (99), squamous cell carcinoma of the oral cavity ( 100) and female breast cancer (101) . Furthermore, neopterin monitoring in the post-thcrapeutic phase can help to detect tumor relapse earlier and may provide an indication for adjuvant therapeutic measures (94) . Nevertheless, it is important to stress that in most cases conventional tumor markers, which are released by the tumor cells themselves, correlate better with tumor growth than neopterin, whereas neopterin concentrations represent a better predictor of patients' survival (94).
The worse prognosis of those with higher neopterin production might be explained by a cellular immune response against the tumor which might be stronger in patients with more aggressive tumors. However, the immune system seems unable to eradicate the malignant process, and a kind of chronic immune activation has been induced. From additional investigations it appears that phenomena like tumor anemia or tumor cachexia, which are often associated with malignant disease, might be a consequence of this immune stimulation. In hematological neoplasias increased neopterin showed a significant inverse correlation with blood hemoglobin (102) . IFN-γ and TNF-a, produced by activated monocytes/macrophages (103), might contribute to these phenomena. Thus, high levels of soluble tumor necrosis factor receptors were reported in hematological neoplasias, the concentrations of which correlated with weight loss as well as with increased neopterin and decreased hemoglobin levels (104).
The finding of increased neopterin concentrations in cancer patients and their predictive value fits very well to the assumption that chronic inflammation and the production of reactive oxygen species may induce DNA damage and mutations and, as a result, be carcinogenic (105, 106) . Thereby, chronic inflammation could be essential for the development and progression of the neoplastic process so that therapeutic interven-lion aimed at inhibiting inflammation may have a major role in future reducing the incidence of common cancers ( 105) .
Neopterin in autoimmune diseases and related inflammatory disorders
In autoimmune diseases an attack of the immune system against homologous structures of the organism occurs. Thus, in case of involvement of cellular immunity neopterin elevations should be expected. And indeed, in rheumatoid arthritis elevated neopterin concentrations are found in blood and urine correlating with the disease activity (106). Highest neopterin levels are seen in synovial fluids of patients during the acute exacerbation of the disease (107) . Neopterin measurement can also be applied as an additional criterion to discriminate rheumatoid arthritis from osteoarthritis, because in the latter case neopterin production is usually within the normal range (108). In patients with systcmic lupus erythematosus neopterin production correlates with disease activity, as well. In a multivariate analysis, neopterin proved as one of the most representative immune activation markers, correlating with disease activity better than, e.g., 55kD-soluble tumor necrosis factor receptor, soluble interleukin-2 receptor or beta-2-microglobulin (109). Increased neopterin production in accordance with disease activity was also demonstrated in Wegener's granulomatosis (110), dermatomyositis (111), and inflammatory bowel diseases, such as Crohn's disease (112, 1 13) and colitis ulcerosa (114).
Neopterin in cardiovascular diseases
Increased neopterin production is also found in patients with dilated cardiomyopathy or chronic myocarditis, correlating with the cardiac functional class according to the New York Heart Association (1 15). As immune activation plays an important role in the pathogenesis of acute rheumatic fever, about 80% of patients show increased neopterin production at the onset of disease. Higher neopterin concentrations are found in patients developing a combined aortic and mitral insufficiency. Thus, neopterin measurement may allow easy assessment of the severity of cardiac involvement in acute rheumatic fever (116). Increased neopterin production was found in atherosclerosis of the coronary (117, 118) and carotid arteries (119) , and in acute and chronic coronary syndromes (120-122). Neopterin was significantly increased in patients with chronic coronary artery disease and more pronounced m patients with acute myocardial infarction (120, 123). An association of serum neopterin concentrations with the presence of angiographically demonstrated complex lesions in patients with unstable angina could be shown, neopterin representing as a marker for coronary disease activity (124). Besides neopterin, other markers of inflammation like C-reactive protein or serum amyloid A are increased in patients with atherosclerosis indicating the inflammatory nature of atherosclerotic disease (117, 118, 125) . However, prognostic value of neopterin levels was almost independent from these other parameters in, e.g., treated patients with hypertension and chest pain but without obstructive coronary artery disease (126). A strong association was found between neopterin concentrations and another cardiovascular risk factor namely hyperhomocysteinemia (127). From the data it appears that development of hyperhomocysteinemia is another consequence of immune activation, degradation of B-vitamins due to oxidative stress might be responsible for disturbed homocysteine conversion.
Neopterin in neurodegenerative diseases
Increased neopterin levels were described rather early in cerebrospinal fluid and other body fluids of patients with multiple sclerosis. They were found to be significantly higher in the acute phase of disease than in stable periods (128), and even the measurement of urinary neopterin concentrations was found as an immunological marker of disease activity in patients with multiple sclerosis and to monitor treatment with interferon-ß (129). Neopterin measurement in cerebrospinal fluid may be able to support differential diagnosis, e.g., it is important to note that patients with amyotrophic lateral sclerosis have normal neopterin levels in serum and CSF (130) .
In neurodegenerative diseases like Alzheimer's dementia or Parkinson's disease, signs of immune activation and increased oxidative stress are evident. However, usually activation of immunocompetent cells and release of reactive oxygen species are considered to be confined to the brain so that oxidative stress might underlie local pathological processes in patients. Increased neopterin concentrations can be found in patients with various forms of dementia such as Alzheimer's disease (131) and Huntington's disease ( 1 32) and vascular dementia (133) but also in patients suffering from Parkinson's disease (134), and interestingly neopterin concentrations are usually higher in the serum/plasma than in the cerebrospinal fluid. The background of this chronic immune stimulation is still unclear. Since it is observed rather in late stages of the disease, it seems to represent a consequence of the underlying pathology rather than being initial. In patients with dementia, neopterin concentrations are associated with the loss of cognitive function, neopterin levels are higher in patients with lower mental state (131) (132) (133) . Likewise, in patients with cardiovascular diseases (127), also in patients with various forms of dementia a relationship between neopterin concentrations and hyperhomocysteinemia has been observed (135). It is still unclcar, if chronic immune activation, indicated by increased neopterin production and by oxidative stress (133), is important in the pathogenesis of this disease, but monitoring of immune activation markers like neopterin might lead to better understanding of disease progression and reveals prognostic information for the future course of the disease. As in other clinical conditions characterized by , e.g., increased neopterin concentrations, chronic immune activation may well contribute to the development of immunodeficiency and weight loss in these patients. The relationship between immune activation and loss of cognitive ability might relate to the link between neopterin production and degradation of tryptophan by enzyme indoleamine (2,3)-dioxygenase (136). Like neopterin production also tryptophan degradation is strongly inducible by cytokine IFN-γ. Insufficient biosynthesis of neurotransmitter serotonin on the basis as a consequence of subnormal tryptophan availability might link cognitive abnormalities with immune activation phenomena.
Neopterin in aging
Scrum neopterin concentrations but also urinary neopterin excretion of healthy children is higher than that of adults and is declining from the newborn period up to adolescence (8, 10) . Highest neopterin concentrations are found in cord blood (95" 1 percentile, 20.9 nM) (137). Higher neopterin production in early childhood may relate to activation of immune response involving adaptive and/or innate immune response (138).
In the elderly neopterin concentrations increase with age (139). This is evident from the age dependency of the reference values of neopterin concentrations in different body fluids and could be confirmed by all so far known studies with healthy individuals (28, 29, MO-MS). The reason for this phenomenon is still a matter >f discussion. Possibly the higher incidence of diseases associated with immune activation in the elderly such . e.g., arteriosclerosis or dementia would contribute higher reference values. Thereby it is assumed that some of the individuals of the reference population -pathological process has already started but is clin---.lv not yet detectable. Correlations exist between increased neopterin concentrations and accelerated tryptophan degradation as well as hyperhomocysteinemia in older aged individuals (139). Data support the view that there is an immunologic background of these neopterin elevations rather than renal dysfunction. From this point of view T-cell abnormalities developing with older age or low level chronic infections could play an important role.
Neopterin in organ transplantation
Monitoring of solid allograft (kidney, heart, liver, pancreas) recipients by neopterin measurements in morning urine or serum/plasma has become a useful tool in surveillance after transplantation. In uncomplicated courses neopterin production decreases to normal values after surgery, whereas sustaining high concentrations indicate an immunological complication such as organ rejection or infection. In recipients of renal allografts it was found that an increase of neopterin production precedes clinical rejection diagnosis up to four days and that high neopterin values during the initial post-transplant period are associated with poorer long-term graft survival (55. 144). Neopterin measurements were also suggested to be useful for differential diagnosis of rejection and infection, but only in combination with other inflammatory parameters (145, 146). In liver transplantation, parallel measurement of neopterin concentrations in urine and bile allows discrimination between ongoing rejection and infection, because excessive bilary neopterin excretion is restricted to rejection episodes but is not found in, e.g., cytomegalovirus infection or hepatitis (147). Also in pancreas transplantation, measurement of neopterin excretion in the pancreatic juice provides additional information about the origin of immune activation (148) . In bone marrow transplantation, neopterin measurement allows to monitor the course of immune system destruction and hemopoietic reconstitution. After hemopoietic reconstitution it enables to discriminate between patients with or without increased risk of developing graft versus host disease and viral infection, respectively (149).
Neopterin in blood transfusion
During the last years considerable progress concerning safety of blood transfusion was achieved either by serologic or molecular biology techniques like polymerase chain reaction (PCR) supporting blood donor screening. Nevertheless, residual infectious risk still remains in blood transfusion. Potential hazardous pathogens may remain undetected either because they are known but not screened or they are unknown so that usually performed screening technologies are ineffective. In addition, it is possible that blood donation is drawn within the diagnostic window -the period between infection and antibody production -of an infectious process so that antibody production is not yet detectable. During acute infections neopterin concentrations in serum generally reach rather high values. This enhanced neopterin production is not specific for a certain infectious disease, but indicates that an immunological process caused by a known or even hitherto unknown pathogen is going on. Thus, applying neopterin measurements for blood donor screening can exclude virus infections during the acute phase when virus load is highest and allows to further shorten the diagnostic window in addition to serologic screening methods (150, 151) . In 1994 neopterin screening of blood donations became compulsory in Austria. Subclinical infections or silent systemic disorders may be detected in a higher frequency by increased neopterin concentrations and suspicious blood units are discarded to increase the security of transfusion (151) . It was shown that in blood donors with neopterin concentrations above 10 nM that acute cytomegalovirus infections which have been unrecognized during anamnesis were about 19 times more frequent than in such infected individuals with neopterin below 10 nM (152). Similarly, the incidence of acute Epstein-Barr virus and parvovirus Β19 infections was accompanied by a about three times higher frequency in individuals with neopterin above 10 nM (153) . Also in chronic and clinically unsuspicious hepatitis C infections PCR-positively tested donations were about seven times more frequent when neopterin was above 10 nM (154).
Neopterin measurements for "in vitro" diagnostics
In cultures of stimulated peripheral blood mononuclear cells (PBMC) neopterin concentrations sensitively indicate IFN-γ production by Thl-type cells. The model system of PBMC stimulated with mitogens like phytohemagglutinine or concanavalin A can be applied to detect possible influences of chemicals, drugs or plant extracts on the activation of the cells. First observations were made with colchicines which significantly suppressed neopterin production (155). Using monocytic cell line THP-1 the influence of histamine to suppress neopterin production was demonstrated (156). However, the application of PBMC turned out to be superior because it allows to monitor the interplay between activation Thl-type cells and macrophages in one cellular system and it seems to mimic more closely what is going on in vivo, e.g. immunosuppressive and anti-inflammatory capacity could be demonstrated for tea extracts (157) and for extracts and alkaloids from Uncaria tomentosa (158) as well as for the Tibetan herbal remedy PADMA 28 (159). In a similar way wine and grape juice were found to suppress neopterin formation and tryptophan degradation in stimulated PBMC (160). All together data indicate that antioxidant compounds are able to down-regulate Thl-type immune response as it was shown earlier for histamine (160). Indeed, antioxidants appear to favor Th2-type immune response whereas pro-oxidants are part of the Thl-type machinery (Fig.  3) (161) .
Also HMG-Co A reductase inhibitor atorvastatin was found to interfere with Thl-type immune activation as it suppressed neopterin and IFN-γ production in the in vitro system of mitogen-treated PBMC (161), and most importantly a similar influence was found in individuals undergoing coronary angiography, patients who were treated with statins presented with significantly lower neopterin concentrations than those not being under such treatment (162).
Finally since also lipopolysaccharides may induce neopterin formation by macrophages, the measurement of neopterin production allows to sensitively detect bacterial pyrogens, it thus provides a simple in vitro assay to detect pyrogenic contamination (163) .
